|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Best Practice
Open Access
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Form
Ethics Disclosure form
All issues
Ahead-of Print Articles
Most Read Articles
Most Cited Articles
Radiation Oncology Journal
Search
Author Index
Previous issue
> Previous issue
Table of Contents | June, 2022 Vol. 40 No.2
Previous Issue
|
Next Issue
|
Archive
In this issue:
▶ Review Article
▶ Original Article
▶ Case Report
Review Article
89
An overview of radiation-induced heart disease
Samer Ellahham, Amani Khalouf, Mohammed Elkhazendar, Nour Dababo, Yosef Manla
Radiat Oncol J.
2022;40(2):89-102. Published online 2022 Jun 21 DOI:
https://doi.org/10.3857/roj.2021.00766
Cited By 5
Original Articles
Clinical Investigations
103
Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
Candan Demiroz Abakay, Sonay Arslan, Meral Kurt, Sibel Cetintas
Radiat Oncol J.
2022;40(2):103-110. Published online 2022 May 25 DOI:
https://doi.org/10.3857/roj.2021.00864
111
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J.
2022;40(2):111-119. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.01060
Cited By 3
120
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu
Radiat Oncol J.
2022;40(2):120-126. Published online 2022 May 17 DOI:
https://doi.org/10.3857/roj.2021.01025
127
Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam
Radiat Oncol J.
2022;40(2):127-140. Published online 2022 Jun 20 DOI:
https://doi.org/10.3857/roj.2021.01053
141
Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Chawalit Lertbutsayanukul, Manida Pitak, Chonnipa Nantavithya
Radiat Oncol J.
2022;40(2):141-150. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.00927
Cited By 1
151
Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis
Radiat Oncol J.
2022;40(2):151-161. Published online 2022 Jun 20 DOI:
https://doi.org/10.3857/roj.2021.01032
Case Report
162
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Rahul N. Prasad, Peter J. Kobalka, Haley K. Perlow, Daniel M. Prevedello, Dukagjin M. Blakaj, Raju R. Raval, Joshua D. Palmer
Radiat Oncol J.
2022;40(2):162-168. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.01074
Cited By 1
> Previous issue
